Bio-Rad Laboratories Comprehensive Income 2010-2024 | BIO
Bio-Rad Laboratories comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
- Bio-Rad Laboratories comprehensive income for the quarter ending September 30, 2024 was $-0.451B, a 21.05% increase year-over-year.
- Bio-Rad Laboratories comprehensive income for 2023 was $-0.336B, a 28.02% decline from 2022.
- Bio-Rad Laboratories comprehensive income for 2022 was $-0.467B, a 165.92% increase from 2021.
- Bio-Rad Laboratories comprehensive income for 2021 was $-0.176B, a 162.15% decline from 2020.
| Bio-Rad Laboratories Annual Comprehensive Income (Millions of US $) |
|
|---|---|
| 2023 | $-336 |
| 2022 | $-467 |
| 2021 | $-176 |
| 2020 | $282 |
| 2019 | $-87 |
| 2018 | $-47 |
| 2017 | $739 |
| 2016 | $418 |
| 2015 | $382 |
| 2014 | $219 |
| 2013 | $341 |
| 2012 | $275 |
| 2011 | $199 |
| 2010 | $198 |
| 2009 | $133 |
| Bio-Rad Laboratories Quarterly Comprehensive Income (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-451 |
| 2024-03-31 | $-426 |
| 2023-12-31 | $-336 |
| 2023-09-30 | $-498 |
| 2023-06-30 | $-373 |
| 2023-03-31 | $-408 |
| 2022-12-31 | $-467 |
| 2022-09-30 | $-845 |
| 2022-06-30 | $-533 |
| 2022-03-31 | $-308 |
| 2021-12-31 | $-176 |
| 2021-09-30 | $-63 |
| 2021-06-30 | $125 |
| 2021-03-31 | $68 |
| 2020-12-31 | $282 |
| 2020-09-30 | $84 |
| 2020-06-30 | $-61 |
| 2020-03-31 | $-149 |
| 2019-12-31 | $-87 |
| 2019-09-30 | $-152 |
| 2019-06-30 | $-50 |
| 2019-03-31 | $-81 |
| 2018-12-31 | $-47 |
| 2018-09-30 | $-32 |
| 2018-06-30 | $-19 |
| 2018-03-31 | $104 |
| 2017-12-31 | $739 |
| 2017-09-30 | $617 |
| 2017-06-30 | $611 |
| 2017-03-31 | $517 |
| 2016-12-31 | $418 |
| 2016-09-30 | $521 |
| 2016-06-30 | $460 |
| 2016-03-31 | $415 |
| 2015-12-31 | $382 |
| 2015-09-30 | $379 |
| 2015-06-30 | $332 |
| 2015-03-31 | $207 |
| 2014-12-31 | $219 |
| 2014-09-30 | $261 |
| 2014-06-30 | $351 |
| 2014-03-31 | $373 |
| 2013-12-31 | $341 |
| 2013-09-30 | $316 |
| 2013-06-30 | $267 |
| 2013-03-31 | $269 |
| 2012-12-31 | $275 |
| 2012-09-30 | $249 |
| 2012-06-30 | $214 |
| 2012-03-31 | $256 |
| 2011-12-31 | $199 |
| 2011-09-30 | $213 |
| 2011-06-30 | $297 |
| 2011-03-31 | $230 |
| 2010-12-31 | $198 |
| 2010-09-30 | $160 |
| 2010-06-30 | $75 |
| 2010-03-31 | $116 |
| 2009-12-31 | $133 |
| 2009-09-30 | $125 |
| 2009-06-30 | $71 |
| 2009-03-31 | $16 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $10.245B | $2.671B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $202.584B | 25.84 |
| Stryker (SYK) | United States | $144.427B | 32.55 |
| Boston Scientific (BSX) | United States | $130.404B | 37.49 |
| Medtronic (MDT) | Ireland | $113.203B | 16.84 |
| EssilorLuxottica (ESLOY) | France | $112.107B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.279B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.049B | 27.97 |
| GE HealthCare Technologies (GEHC) | United States | $39.012B | 20.24 |
| ResMed (RMD) | United States | $36.507B | 30.00 |
| Terumo (TRUMY) | Japan | $30.649B | 43.28 |
| Koninklijke Philips (PHG) | Netherlands | $24.871B | 19.04 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.791B | 13.87 |
| Insulet (PODD) | United States | $19.339B | 77.01 |
| Baxter (BAX) | United States | $17.458B | 11.37 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.816B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.218B | 38.97 |
| Demant (WILYY) | Denmark | $8.351B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.846B | 13.58 |
| TG Therapeutics (TGTX) | United States | $4.785B | 0.00 |
| Haemonetics (HAE) | United States | $4.590B | 22.40 |
| ICU Medical (ICUI) | United States | $4.354B | 41.56 |
| Prestige Consumer Healthcare (PBH) | United States | $4.039B | 20.09 |
| Perrigo (PRGO) | Ireland | $3.645B | 10.73 |
| Envista Holdings (NVST) | United States | $3.571B | 26.60 |
| Neogen (NEOG) | United States | $3.554B | 41.00 |
| Agios Pharmaceuticals (AGIO) | United States | $3.448B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $3.068B | 19.67 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.891B | 18.61 |
| LeMaitre Vascular (LMAT) | United States | $2.372B | 57.65 |
| Warby Parker (WRBY) | United States | $2.084B | 0.00 |
| AtriCure (ATRC) | United States | $1.862B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.651B | 28.90 |
| InMode (INMD) | Israel | $1.638B | 9.85 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.458B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.405B | 10.05 |
| BioLife Solutions (BLFS) | United States | $1.227B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.079B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.035B | 18.25 |
| Owens & Minor (OMI) | United States | $1.031B | 8.05 |
| CeriBell (CBLL) | United States | $0.983B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.931B | 31.10 |
| Capricor Therapeutics (CAPR) | United States | $0.887B | 0.00 |
| Evolus (EOLS) | United States | $0.831B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.598B | 18.04 |
| Quanterix (QTRX) | United States | $0.588B | 0.00 |
| Surmodics (SRDX) | United States | $0.549B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.546B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.508B | 0.00 |
| Valneva SE (VALN) | France | $0.417B | 0.00 |
| ZimVie (ZIMV) | United States | $0.394B | 33.19 |
| Canopy Growth (CGC) | Canada | $0.379B | 0.00 |
| Cerus (CERS) | United States | $0.377B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.370B | 35.22 |
| OraSure Technologies (OSUR) | United States | $0.316B | 21.20 |
| Biote (BTMD) | United States | $0.312B | 14.38 |
| Sanara MedTech (SMTI) | United States | $0.306B | 0.00 |
| Zynex (ZYXI) | United States | $0.296B | 62.00 |
| MacroGenics (MGNX) | United States | $0.276B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.262B | 0.00 |
| Jin Medical (ZJYL) | China | $0.250B | 0.00 |
| Omeros (OMER) | United States | $0.249B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.238B | 16.05 |
| High Tide (HITI) | Canada | $0.213B | 88.33 |
| TerrAscend (TSNDF) | Canada | $0.196B | 0.00 |
| Brainsway (BWAY) | Israel | $0.180B | 216.00 |
| Organigram Holdings (OGI) | Canada | $0.169B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.155B | 20.99 |
| Rockwell Medical (RMTI) | United States | $0.144B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.140B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.137B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.117B | 0.00 |
| Veru (VERU) | United States | $0.106B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 9.76 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 23.20 |
| Cellectar Biosciences (CLRB) | United States | $0.086B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.081B | 0.00 |
| Sanuwave Health (SNWVD) | United States | $0.079B | 2.69 |
| Modular Medical (MODD) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.066B | 0.00 |
| Safety Shot (SHOT) | United States | $0.061B | 0.00 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| MariMed (MRMD) | United States | $0.055B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.053B | 0.00 |
| Exagen (XGN) | United States | $0.052B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.047B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Senestech (SNES) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 13.60 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |